U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C10H12N4O8S
Molecular Weight 348.289
Optical Activity UNSPECIFIED
Defined Stereocenters 4 / 4
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of INOSINE 5'-SULFATE

SMILES

O[C@@H]1[C@@H](COS(O)(=O)=O)O[C@H]([C@@H]1O)N2C=NC3=C2N=CNC3=O

InChI

InChIKey=IGYLPKLXFDOQGM-KQYNXXCUSA-N
InChI=1S/C10H12N4O8S/c15-6-4(1-21-23(18,19)20)22-10(7(6)16)14-3-13-5-8(14)11-2-12-9(5)17/h2-4,6-7,10,15-16H,1H2,(H,11,12,17)(H,18,19,20)/t4-,6-,7-,10-/m1/s1

HIDE SMILES / InChI

Molecular Formula C10H12N4O8S
Molecular Weight 348.289
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 4 / 4
E/Z Centers 0
Optical Activity UNSPECIFIED

Approval Year

Substance Class Chemical
Created
by admin
on Mon Mar 31 23:27:11 GMT 2025
Edited
by admin
on Mon Mar 31 23:27:11 GMT 2025
Record UNII
SJ1W653O6G
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
INO-2002
Preferred Name English
INOSINE 5'-SULFATE
Systematic Name English
INOSINE, 5'-(HYDROGEN SULFATE)
Systematic Name English
5'-IMS
Common Name English
((2R,3S,4R,5R)-3,4-DIHYDROXY-5-(6-HYDROXYPURIN-9-YL)TETRAHYDROFURAN-2-YL)METHYL HYDROGEN SULFATE
Systematic Name English
IMS
Common Name English
Code System Code Type Description
SMS_ID
100000077347
Created by admin on Mon Mar 31 23:27:11 GMT 2025 , Edited by admin on Mon Mar 31 23:27:11 GMT 2025
PRIMARY
CAS
1091624-25-7
Created by admin on Mon Mar 31 23:27:11 GMT 2025 , Edited by admin on Mon Mar 31 23:27:11 GMT 2025
NO STRUCTURE GIVEN
CAS
70023-32-4
Created by admin on Mon Mar 31 23:27:11 GMT 2025 , Edited by admin on Mon Mar 31 23:27:11 GMT 2025
PRIMARY
FDA UNII
SJ1W653O6G
Created by admin on Mon Mar 31 23:27:11 GMT 2025 , Edited by admin on Mon Mar 31 23:27:11 GMT 2025
PRIMARY
DRUG BANK
DB05973
Created by admin on Mon Mar 31 23:27:11 GMT 2025 , Edited by admin on Mon Mar 31 23:27:11 GMT 2025
PRIMARY
PUBCHEM
135494187
Created by admin on Mon Mar 31 23:27:11 GMT 2025 , Edited by admin on Mon Mar 31 23:27:11 GMT 2025
PRIMARY
Related Record Type Details
SALT/SOLVATE -> PARENT
Related Record Type Details
ACTIVE MOIETY
The aim of this study was to determine whether a metabolic resistant purine analog, INO-2002, exerts anti-inflammatory effects in an animal model of acute respiratory distress syndrome. Mice challenged with intratracheal LPS (50 microg) were treated with INO-2002 (30 or 100 mg kg(-1), i.p.) in divided doses at either 1 and 12 h or at 5 and 16 h. After 24 h, bronchoalveolar lavage fluid was obtained to measure leukocyte infiltration by myeloperoxidase levels, lung edema by protein levels, and proinflammatory chemokine (macrophage inflammatory protein 1alpha) and cytokine (TNF-alpha, IL-1, and IL-6) levels. INO-2002 (30 and 100 mg kg(-1)) reduced the LPS-mediated infiltration of leukocytes and edema as evidenced by bronchoalveolar lavage fluid reduction in levels of myeloperoxidase and protein.